Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)
Public ClinicalTrials.gov record NCT01581593. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Open-label, Historically Controlled, Phase III Study to Assess the Efficacy, Tolerability, Safety and Pharmacokinetics of Kedrion IVIG 10% in Adult and Pediatric Subjects With Primary Immunodeficiency (PID).
Study identification
- NCT ID
- NCT01581593
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Kedrion S.p.A.
- Industry
- Enrollment
- 45 participants
Conditions and interventions
Interventions
- Kedrion IVIG 10% Biological
Biological
Eligibility (public fields only)
- Age range
- 2 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 11, 2012
- Primary completion
- Aug 26, 2014
- Completion
- Aug 26, 2014
- Last update posted
- Feb 15, 2021
2012 – 2014
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | — |
| Allergy Associates of the Palm Beaches | North Palm Beach | Florida | 33408 | — |
| Family Allergy & Asthma Center, PC | Atlanta | Georgia | 30342 | — |
| Rush University | Chicago | Illinois | 60612 | — |
| University of Iowa Hospital and Clinics | Iowa City | Iowa | 52242 | — |
| Midwest Immunology Clinic | Plymouth | Minnesota | 55446 | — |
| AAIR Research Center | Rochester | New York | 14618 | — |
| Optimed Research, LTD | Columbus | Ohio | 43235 | — |
| Dallas Allergy Immunology Research | Dallas | Texas | 75230 | — |
| AARA Research Center | Dallas | Texas | 75231 | — |
| Virginia Commonwealth University Health Systems | Richmond | Virginia | 23298 | — |
| Marycliff Allergy Specialists | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01581593, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 15, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01581593 live on ClinicalTrials.gov.